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Abstract The mitochondrial membrane bound dihydroorotate
dehydrogenase (DHODH; EC 1.3.99.11) catalyzes the fourth
step of pyrimidine biosynthesis. By the present correction of a
known cDNA sequence for Arabidopsis thaliana DHODH
we revealed the importance of the very C-terminal part for its
catalytic activity and the reason why ^ in contrast to mammalian
and insect species ^ the recombinant plant £avoenzyme was un-
accessible to date for in vitro characterization. Structure^activity
relationship studies explained that potent inhibitors of animal
DHODH do not signi¢cantly a¡ect the plant enzyme. These dif-
ference could be exploited for a novel approach to herb or pest
growth control by limitation of pyrimidine nucleotide pools.
0 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
In plants the de novo pathway for the biosynthesis of ur-
idine monophosphate has a gene and cell compartment orga-
nization scheme di¡erent from that in animals [1^4]. The ¢rst
three enzymes, carbamyl phosphate synthetase, aspartate
transcarbamylase, dihydroorotase, are monofunctional and
the last two enzymes orotate phosphoribosyltransferase and
orotidine-5P-monophosphate decarboxylase, are part of the
multifunctional protein UMP-synthase (for review see [5,6]).
These enzymes have been localized in chloroplasts [4]. Their
animal equivalents, the CAD enzyme (catalyzing steps 1^3
inclusive) and the UMP-synthase are cytosolic [7]. Dihydroor-
otate dehydrogenase (DHODH) catalyzes the fourth step, the
oxidation of dihydroorotate to orotate. In animals this en-
zyme has been shown to be a monomeric integral membrane
£avoprotein, located at the outer surface of the inner mito-
chondrial membrane, where it transfers the electrons via £a-
vinmononucleotide (FMN) to the co-substrate ubiquinone of
the respiratory chain [7^9]. On the basis of amino acid se-
quence comparison, the enzymes of eukaryotes ^ animals,
plants, unicellular organisms ^ together with the membrane-
associated DHODH from Gram-negative bacteria, have been
grouped together as family 2. Their soluble counterparts in
Gram-positive bacteria and Saccharomyces cerevisiae belong
to family 1. These are homodimeric or heterodimeric enzymes
that use di¡erent electron acceptors [10,11]. Due to their anti-
in£ammatory, immunosuppressive, cytostatic or anti-parasitic
e¡ects, DHODH inhibitors, depressing the intracellular level
of pyrimidine nucleotides, have been investigated in several
organisms [12^16]. The availability of the recombinant hu-
man, mouse and rat DHODH allowed mode of action studies
with such inhibitors [12,17^19]; some of these are in clinical
use today, e.g. the anti-rheumatic drug le£unomide (Arava1)
[12], the anti-malarial drug atovaquone (Malarone1) [15] and
the anti-coccidial toltrazuril (Baycox1) [16]. The development
of e¡ective compounds against Plasmodium falciparum and
Pneumocystis carinii took advantage of species speci¢c di¡er-
ences between DHODH from family 2. New lead structures
have been identi¢ed and proposed for further application
[20,21]. In contrast to the wealth of information about
DHODH in animals and microorganisms, relatively little is
known about DHODH in plants. The activity of DHODH
has been shown to be related with functional mitochondria
from pea and tomato leaves [4,22] and a cDNA clone coding
for the mitochondrial DHODH from Arabidopsis thaliana was
reported to complement a DHODH de¢ciency in yeast by
Mine¤t et al. [23]. In this study a functional open reading frame
(ORF) for the mitochondrial DHODH from A. thaliana (acc.
no. AF454729) is reported and the over-expressed enzyme
characterized for substrate speci¢city and inhibition. Our
work renders a necessary contribution to close the gap in
the knowledge of plant pyrimidine biosynthetic enzymes.
2. Materials and methods
2.1. Materials
Special chemicals, dihydroorotate, decylubiquinone (QD), decylplas-
toquinone (PQD), 2,3-dimethoxy-5-methyl-p-benzoquinone, and 2,6-
dichlorophenol-indophenol (DCIP) were from Sigma, Germany. 2,5-
Dimethyl-p-benzoquinone (PQ0) was from Acros, Belgium. Ubiqui-
none-50 (Q10) was from Kaneka, Japan. A77-1726 (2-hydroxyethyli-
dene-cyanoacetic acid 4-tri£uoromethyl anilide N-2-hydroxyethylpi-
perazine) the active metabolite of ARAVA1 was obtained from
Aventis, brequinar sodium (NSC 368390, 6-£uoro-2-(2P-£uoro-1,1P-
biphenyl-4-yl)-3-methyl-4-quinoline carboxylic acid sodium) from Du-
0014-5793 / 02 / $22.00 L 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 2 ) 0 3 4 2 5 - 7
*Corresponding author. Fax: (49)-6421-2865116.
E-mail addresses: ullricha@mailer.uni-marburg.de (A. Ullrich),
wolfgang.knecht@astrazeneca.com (W. Knecht),
jp@biocentrum.dtu.dk (J. Piskur), loe¥er@mailer.uni-marburg.de
(M. Lo«¥er).
1 Present address: Astra Zeneca RpD Mo«lndal, S-431 83 Mo«lndal,
Sweden
Abbreviations: DHODH, dihydroorotate dehydrogenase (EC
1.3.99.11); DHO, L-dihydroorotate; QD, decylubiquinone; Q10, ubi-
quinone-50; PQD, decylplastoquinone; PQ0, 2,5-dimethyl-p-benzoqui-
none; DCIP, 2,6-dichlorophenol-indophenol
FEBS 26606 27-9-02
FEBS 26606FEBS Letters 529 (2002) 346^350
Pont Pharma GmbH, Germany. The vector pASK75 was from Bio-
metra, Germany.
Synthetic oligonucleotides were from MWG-Biotech (Germany).
AT-for1a: 5P-CTAGTCTAGATAACGAGGGCAAAAAATGGCC-
GGAAGGGCTGCGACGTCGTCGGCG; AT-for2a: 5P-CTAGTC-
TAGATAACGAGGGCAAAAAATGAGTACTGCAGATGAAGC-
AACCTTCTGTGGGT; AT-rev5: 5P-CGGAATTCTCTGTGATCA-
GCACCAATTGCTT.
2.2. Construction of expression vectors
Two vectors to express the complete DHODH and a N-terminal
truncated protein lacking the ¢rst 75 amino acids were constructed.
The ORFs for both DHODHs were ampli¢ed with PCR, generating a
XbaI-site with the forward primers (AT-for1a and AT-for2a) and a
EcoRI-site with the reverse primer (AT-rev5). The vector pPyrD ARA
[23] (from Dr. M. Mine¤t, Centre de Ge¤ne¤tique Mole¤culaire, CNRF,
F-91190-Gif-sur-Yvette), containing A. thaliana DHODH cDNA was
used as a template. The PCR fragments were cut with XbaI and
EcoRI and replaced the ORF of the rat DHODH in the vector
pASK-C. This vector has been described in detail by Bader et al.
[24]. The resulting expression vectors were named: pASK-AT and
pASK-v75AT; the cDNA sequences were veri¢ed by sequencing
(TopLab, Munich). The recombinant proteins expressed from these
vectors are referred to as AT-DHODH and v75AT-DHODH and
both have a ^Glu-Phe-(His)8 tag (8xhis) at the C-terminus.
2.3. Expression and puri¢cation of A. thaliana DHODH
Transformed Escherichia coli XL-1 (Stratagene) were grown to
A578nm = 0.5^0.6 in Luria broth medium with 100 Wg/ml ampicillin.
Protein expression was induced by 200 Wg/l anhydrotetracyclin and
carried at room temperature with the addition of 100 WM FMN for
48 h. The recombinant histidine-tagged proteins were gained from
separation on Ni2þ-nitrilotriacetate agarose [24]. AT-DHODH was
puri¢ed in bu¡er containing 0.1% Triton X-100, while v75AT-
DHODH did not require the presence of detergents for puri¢cation.
Protein content was determined by means of the bicinchoninic acid
protein assay with bovine serum albumin as standard; fractions from
the puri¢cation procedure were analyzed by SDS^PAGE; £avin anal-
ysis was performed spectrophotometrically as described previously [24].
2.4. Enzyme assay
All activity studies were performed with the oligo-histidine-tagged
enzyme. The oxidation of the substrate L-dihydroorotate (DHO) with
the quinone co-substrate was coupled to the reduction of the chrom-
ogen DCIP. The standard assay contained 1 mM DHO, 0.1 mM QD,
0.06 mM DCIP, 50 mM Tris/HCl, 150 mM KCl, pH 8.0, and 0.08%
Triton X-100 (for solubilization of quinones) at 30‡C. The 10 mM
stocks of the agents brequinar and A77-1726 were dissolved in the
same bu¡er. Stock solutions of QD and the other quinones were of
10 mM or 50 mM in ethanol. For the determination of kinetic con-
stants, the formation of orotate was directly followed by monitoring
the increase in it absorbance at the isosbestic wavelength of QD at
300 nm (O300nm = 2950 M31 cm31 ).
2.5. Kinetic analysis
2.5.1. Km and kcat determination. Family 2 DHODH with two
di¡erent binding sites for the two substrates followed a non-classical
ping-pong mechanism [25]. To determine true Km and Vmax values, the
concentration of DHO was varied from 5 to 500 WM at ¢ve ¢xed
concentrations of QD (30, 50, 100, 200, 500 WM); respectively, the
concentration of QD was varied from 30 to 500 WM at ¢ve ¢xed
concentrations of DHO (5, 10, 50, 200, 500 WM). The equation
for a ping-pong mechanism v=VU[DHO]U[quinone]/(Km ðDHOÞU
[quinone]+Km ðquinoneÞU[DHO]+[DHO]U[quinone]) was ¢t to the
data by means of a computer program (Sigma plot 5, Jandel Scien-
ti¢c) that provides an iterative non-linear least squares ¢t to the best
rectangular hyperbola. The kcat values were calculated using the equa-
tion Vmax = kcatU[E], where [E] = total enzyme concentration and is
based on one binding site/monomer for each of the both substrates.
2.5.2. pH dependence. Initial velocities at substrate concentrations
of 1 mM DHO and 0.1 mM QD were measured in di¡erent bu¡er
systems (Mes/HCl, Hepes/HCl, Tris/HCl) covering a range from 5.5 to
9.0. Overlapping pH ranges were measured in two bu¡er systems to
exclude salt e¡ects. The equation: v=V/[(103pH/103pKa1 )+(103pKa2 /
103pH)+1] was ¢t to the data.
3. Results and discussion
3.1. Sequence analysis of A. thaliana DHODH
The comparison of the DHODH cDNA of A. thaliana (acc.
no. X62909) [23] with the recently published genomic se-
quence of A. thaliana [26] revealed a divergence in one base
(Fig. 1). By resequencing of the plasmid pPyrD ARA [23] we
detected an additional thymidine not included in X62909. The
frameshift caused by this lack in the X62909 de¢ned a pre-
mature stop-codon resulting in a truncated ORF (Fig. 1). The
new ORF for the DHODH from A. thaliana has been sub-
mitted to GenBank with the acc. no. AF454729. The sequence
established here matches the genomic sequence of A. thaliana.
Our prediction of the ORF for the A. thaliana DHODH not
only resulted in a signi¢cantly prolonged C-terminus in com-
parison to the previously suggested ORF (acc. no. X62909)
[23] but also to the ORF (acc. No. BAB11185) predicted by
computional analysis of the A. thaliana genome. The latter
can be explained by the fact that the computer predicted
stop-codon lies within an intron. Interestingly, the length of
the C-terminus given by our approach is very close to that
known for DHODH from di¡erent mammals (Fig. 2b). The
complete amino acid sequence deduced from the plant
DHODH cDNA revealed a 48.5 kDa protein and 54.9% iden-
tity and 63.6% similarity with the human DHODH. The im-
portance of the very C-terminal part for catalytic activity of
DHODH was emphasized by the study of Davis et al. [27]
who showed that a his364ala mutant of a N-terminal trun-
cated (his394 in the full-length) human DHODH was inactive.
We found that the expression of a C-terminal truncated
A. thaliana DHODH in accordance to the previously pre-
dicted ORF given in acc. no. X62909 [23] resulted in an
inactive protein (data not shown) in contrast to the active
enzyme containing his421 (Fig. 2b).
3.2. Production of recombinant A. thaliana DHODH for
evaluation of enzyme properties
Expression vectors were constructed to produce a full-
length (AT-DHODH) and a N-terminal truncated (v75AT-
DHODH) version of the A. thaliana protein (Fig. 2a), lacking
the bipartite mitochondrial targeting motif which governs im-
port (targeting sequence) and correct insertion (transmem-
brane sequence) into the mitochondrial inner membrane [9].
The arrow in Fig. 2a marks the start of the N-terminal trun-
cated protein expressed and puri¢ed in this study. Crude bac-
terial extracts showed an enzyme activity of around 0.1 U/mg
cell protein for AT-DHODH; the activity of v75AT-DHODH
was around 5.0 U/mg. The di¡erent expression levels of the
proteins were consistently obtained in multiple experiments.
For puri¢cation purposes, the full-length protein was handled
with 0.1% Triton X-100, while the truncated mutant was sta-
ble without detergents in the bu¡er. Following puri¢cation of
the full-length and truncated DHODH, the SDS^PAGE in
Fig. 3 shows protein bands in the expected molecular mass
range (close to the 45 kDa marker protein). The band of AT-
DHODH is below that of v75AT-DHODH, which is in con-
trast to the calculated molecular mass (AT-DHODH-
8His = 50.9 kDa, v75AT-DHODH-8His = 43.2 kDa). This un-
conventional behavior can be explained, because the long
N-terminal mitochondrial targeting sequence of AT-DHODH
contains numerous positively charged amino acids and, con-
sequently, could bind a higher amount of SDS molecules.
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3.3. Kinetic characterization and inhibition of A. thaliana
DHODH
Since activity measurements of the recombinant full-length
enzyme across a wide range of pH (5.5^9.0) revealed a max-
imum of activity at pH 7.5 (data not shown), all assays were
performed at this value. From the characteristic bell shaped
activity pro¢le, two pKa values (pKa1 = 6.5; pKa2 = 8.8) could
be calculated. For comparison, the optimum of the verte-
brates and insect species was at pH 8.0 [19,24,28].
When tested with QD as electron acceptor, the kcat value for
the truncated DHODH was found to be considerably higher
than that for the full-length enzyme (Table 1), whereas the
£avin content of the two proteins was similar (AT-DHODH:
0.8^1.1 mol £avin/mol protein; v75AT-DHODH: 0.6^0.9 mol
£avin/mol protein). From these data it can be concluded that
the di¡erence in kcat was not due to a di¡erent content of the
cofactor FMN in the puri¢ed proteins. Rather, it is not un-
reasonable to assume that the long N-terminal mitochondrial
targeting sequence of 57 amino acids ^ in comparison to 10
amino acids of the mammalian species ^ could be of unfavor-
able in£uence on the correct folding and stability of the pro-
tein over-expressed in E. coli. This assumption can be con-
cluded from the lower expression rate obtained for the full-
length plant enzyme in our study, as well as for the full-length
P. falciparum DHODH in contrast to the appropriate N-ter-
minal truncated mutant (G. McConkey, University of Leeds,
personal communication on ¢rst experiments). For compari-
son, the expression rate and kcat values of the puri¢ed mam-
malian DHODH did not give the same pattern when compar-
ing the full-length and truncated versions (e.g. human: 107 s31
and 75 s31, respectively [19]).
A non-classical two-site ping-pong mechanism, typical of an
enzyme that contains two non-overlapping and kinetically iso-
lated substrate binding sites, has been described with
DHODH isolated from bovine liver [25]. When our data for
AT-DHODH were plotted in double-reciprocal form, the typ-
ical pattern of parallel straight lines for this kind of mecha-
nism was obtained for the co-substrate QD (not shown). As
can be seen from Table 1, the Km values (40 WM DHO for
AT-DHODH; 121 WM DHO for v75AT-DHODH) were no-
ticeably higher than those of the full-length and truncated
mammalian enzymes (e.g. human: 6 WM and 9 WM [19,24]).
An even more pronounced di¡erence was obtained for QD.
Whereas the Km value of both versions of the human enzyme
was 14 WM, that of the the full-length plant enzyme was
112 WM, and of the truncated plant DHODH it was 341 WM
with this quinone.
Here, we compared the activity of AT-DHODH and
v75AT-DHODH with a variety of quinone acceptors
(Table 2). Q10 is present in all parts of the plant whereas
plastoquinone and menaquinones (vitamin K1 and K2) seem
to occur only in green tissues [29]. The endogenous electron
acceptor of AT-DHODH is not known. Because the long
isoprene side-chain of natural quinones caused solubility
problems in enzyme assays, they often were replaced by the
appropriate quinones without side chain or by QD since this
Fig. 1. Resequencing of the plasmid pPyrD ARA containing the cDNA of A. thaliana DHODH (acc. no. X62909). Partial alignment of the se-
quence established in this study (acc. no. AF454729) and the previously published sequence from X62909 [23]. The premature and the correct
stop-codon as well as the additional thymidine, ‘t’, are marked in gray.
Fig. 2. a: Partial alignment of the N-termini of human and A. thaliana DHODH. Conserved amino acids are marked in gray. MS: Mitochon-
drial targeting sequence, TM: hydrophobic transmembrane sequence. b: Partial alignment of the predicted C-terminal amino acid sequence of
human and A. thaliana DHODH. AF454729: Established in this study. X62909: Sequence communicated by Mine¤t et al. [23]. M94065: Human
DHODH.
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has been commercially available. As previously reported for
the animal DHODH [24,28], under the chosen test conditions
QD was found to give an elevation of the plant DHODH
activity in comparison to the natural Q10 ; PQD was similar
to QD. Interestingly, the replacement of QD by Q0 or PQ0
(Table 2) revealed a comparable or even enhanced activity
of the full-length plant enzyme, but not of the truncated
one. The same tendency was seen with menadione (vitamin
K3) at higher concentration. For comparison, the activity of
the full-length insect DHODH activity was found to be re-
duced by 20^60% on addition of these quinones as alternative
electron acceptors [29]. Similar observations were described
when Q0, vitamin K1 or menadione were tested instead of
Q10 or Q6 with the isolated human or bovine enzyme
[14,25]. These ¢ndings point to a considerable interference
of the long N-terminal mitochondrial targeting sequence of
the AT-DHODH (57 amino acids versus 19 of the insect
and 10 of the human enzyme) with the side chain of the
quinone. Whereas human, rat and insect DHODH were
shown to be not proteolytically processed during import in
mitochondria in vivo and in vitro [9], it is not known for
the plant DHODH whether the N-terminal segment with the
mitochondrial-targeting presequence is cleaved o¡ or not.
In plants, strategies of limiting the pyrimidine nucleotide
pools with the rationale of growth manipulation have not
received much attention to date. Rather, the metabolic inhib-
itors 5-£uorouracil, 5-£uoroorotic acid and N-phosphonoace-
tyl-L-asparate, which are toxic to plant cells just as to animal
cells [5,6], have been used as tools to understand the regula-
tion and expression of pyrimidine biosynthesis in plants. Be-
cause speci¢c inhibitors for DHODH of these organisms have
not been described, we investigated the recombinant plant
enzyme for its susceptibility to two compounds already prov-
en as potent inhibitors of the mammalian DHODH in the
nanomolar range: brequinar, originally developed as cyto-
static agent [14] and A77-1726 with anti-in£ammatory e⁄cacy
pro¢le [12]. The present study revealed only a marginal inhib-
itory e¡ect on A. thaliana DHODH: in the presence of 100 WM
A77-1726, the activity of the full-length DHODH was reduced
only by 10%, that of the truncated one was reduced by 25%.
The residual activity of both enzymes was 90^95% in the
presence of 100 WM brequinar. This negligible e¡ect of bre-
quinar may be explained by sequence and structure analysis of
DHODH. The high resolution crystal structure that has been
provided for an N-terminal truncated human DHODH in
complex with brequinar [18] reveals key interactions that
could govern e¡ective binding of this compound. First, the
carboxylate hydrogen of the brequinar molecule bonds to
the side chain of Gln47 and a water molecule forms hydrogen
bonds with the carboxylate and the Q-oxygen of Thr360.
Gln47 of the human enzyme is replaced by Phe92 in AT-
DHODH and Thr360 is replaced by Ala425. Second, the bi-
phenyl group of the drug was shown to have four hydropho-
bic contacts with side chains of amino acids, one of which,
Leu68, is replaced by Val113 in the plant enzyme. These dif-
ferences in the human and plant protein could be responsible
for the marginal e¡ect observed here with this cinchoninic
acid derivative. In contrast, Arg136, which gives a salt bridge
Fig. 3. SDS^PAGE of AT-DHODH-8His and v75AT-DHODH-
8His puri¢ed on Ni2þ-NTA chromatography. M: Molecular mass
marker. Lane 1: v75AT-DHODH-8His. Lane 2: AT-DHODH-8His
(2 Wg protein per lane).
Table 1
Kinetic constants of the puri¢ed truncated and full-length A. thali-
ana DHODH
AT-DHODH v75AT-DHODH
kcat (s31) 8.2 72.9
QD
Km (WM) 112[ 26 341[ 99
kcat/Km (M31 s31) 73 214 213 783
DHO
Km (WM) 40[ 10 121[ 37
kcat/Km (M31 s31) 205 000 602 479
The concentration of DHO was varied from 5 to 500 WM at ¢ve
¢xed concentrations of QD (30, 50, 100, 200, 500 WM). The concen-
tration of QD was varied from 30^500 WM at ¢ve ¢xed concentra-
tions of DHO (5, 10, 50, 200, 500 WM). Results are means[S.D.
from three measurements. The kcat values were calculated using the
equation Vmax = kcatU[E], where [E] = total enzyme concentration
and is based on one binding site/monomer for each of the both sub-
strates.
Table 2
Use of di¡erent quinone electron acceptors by recombinant A. thaliana DHODH
Electron acceptor 100 WM 500 WM
AT-DHODH v75AT-DHODH AT-DHODH v75AT-DHODH
QD 100 100 100 100
Q0 102[ 10 67[ 8 129[ 17 67[9
PQ0 95[ 23 75[ 10 118[ 24 66[17
Q10 83[ 12 76[ 17 n.d. n.d.*
PQD 95[ 7 104[ 5 68[ 2 86[6
menadione** 82[ 1 78[ 11 103[ 9 74[18
Speci¢c activities observed in the presence of di¡erent quinone derivatives are expressed relative to activity in the presence of QD (set as 100%).
Quinone derivates were tested at 100 WM and 500 WM with the standard chromogen reduction assay. Results are expressed as mean percentage
activity[ S.D. (n=8, 100 WM; n=5, 500 WM). (*) Not determined, solubility problems; (**) n=5.
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to brequinar, and Tyr356 form hydrogen bonds with A77-
1726 in the human enzyme. Both amino acids are conserved
at the respective position in the AT-DHODH sequence,
Arg181 and Tyr421. Since a faint susceptibility of the plant
enzyme to A77-1726 was observed, studies with other repre-
sentatives of this class of compounds would be necessary to
state more precisely the isoxazole suitability as a lead for
development of speci¢c inhibitors.
3.3.1. Concluding remarks. This is the ¢rst study and
characterization of a puri¢ed recombinant plant DHODH,
an enzyme that occupies a central position in de novo pyrim-
idine biosynthesis and that has become a focal point for clin-
ical and therapeutical manipulation of the pathway in hu-
mans, animals and pathogens [30]. In addition, DHODH
from agronomically important fungi has been identi¢ed as a
new antifungal target [21]. Only recently, the di¡erences in
responses of insect DHODH and the enzyme from other spe-
cies have been recognized as promising for the design of new
agents that could selectively control insect growth due to py-
rimidine nucleotide limitation thus contributing to animal and
plant health [28]. With respect to the symbiosis of plants,
insects and fungi and also in view of the immense importance
of intact pyrimidine metabolism for the production of poly-
saccharides and secondary metabolites in plants, we now
bring in the plant DHODH; this to be exploited as putative
target enzyme in the development of novel growth control
strategies, but also to be considered as vulnerable host when
compounds are administered to combat parasites, pathogenes
and insects.
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